ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Fujifilm sharpening focus on biologics contract manufacturing

Plans to more than double culture tank capacity by 2019

Fujifilm's facility in the U.S. state of North Carolina.

TOKYO -- Fujifilm Holdings plans to expand its biopharmaceutical contract manufacturer business by more than doubling the capacity of its culture tanks by 2019 and hiring more engineers to manage its production operations to provide manufacturing services to the pharmaceutical industry.

By adding capacity and taking on more work, Fujifilm aims to more-than triple the fiscal 2016 revenues of its contract manufacturing business to 100 billion yen in fiscal 2023.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more